Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Fallahi, B. [1 ]
Beiki, D. [1 ]
Takavar, A. [1 ]
Eftekhari, M. [1 ]
Fard-Esfahani, A. [1 ]
Gilani, K. Ansari [1 ]
Saghari, M. [1 ]
机构：
[1] Univ Tehran Med Sci, Res Inst Nucl Med, Tehran, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [21] Pulmonary I-131 Radioiodine Clearance in Patients with Differentiated Thyroid Carcinoma.
    Selkinski, I.
    Happel, C.
    Middendorp, M.
    Plastowez, W.
    Sauter, B.
    Kranert, T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S427 - S427
  • [22] THYROGLOBULIN RADIOIMMUNOASSAY AND I-131 SCINTIGRAPHY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    LINDEGAARD, MW
    PAUS, E
    HOIE, J
    KULLMAN, G
    STENWIG, AE
    ACTA CHIRURGICA SCANDINAVICA, 1988, 154 (02): : 141 - 145
  • [23] Comparison of efficacy of 2 220 MBq versus 3 700 MBq I-131 for ablation of thyroid remnant in patients with differentiated thyroid cancer
    Fish, S. A.
    Basu, S.
    Alavi, A.
    Mandel, S. J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (05): : 560 - 563
  • [24] I-131 WHOLE-BODY SCAN FOR POSTSURGICAL FOLLOW-UP OF DIFFERENTIATED THYROID-CARCINOMA
    DEGROSSI, OJ
    DELRIO, HG
    DEGROSSI, EB
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (09) : 1826 - 1826
  • [25] ABLATION DOSE OF I-131 FOR POSTOPERATIVE REMNANT
    PARK, HM
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (08) : 1640 - 1641
  • [26] I-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scans
    Akgun, A.
    Yazici, B.
    Erdim, O.
    Ozcan, Z.
    Ozkilic, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S330 - S330
  • [27] TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
    Ju, Nianting
    Hou, Liying
    Song, Hongjun
    Qiu, Zhongling
    Wang, Yang
    Sun, Zhenkui
    Luo, Quanyong
    Shen, Chentian
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [28] Salivary glands retention on the I-131 diagnostic WBS for patients with differentiated thyroid carcinoma with a single or multiple I-131 therapies
    Saranti, S.
    Antoniou, D.
    Diamantakis, K.
    Papadouli, D.
    Rethymniotakis, K.
    Moschoyiannis, V.
    Georgakopoulos, A.
    Pateniotis, K.
    Matselas, E.
    Trivizaki, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S450 - S450
  • [29] Salivary glands retention on the I-131 diagnostic WBS for patients with differentiated thyroid carcinoma with a single or multiple I-131 therapies
    Gaberscek, S.
    Zaletel, K.
    Osolnik, J.
    Bajuk, N. Bedernjak
    Pirnat, E.
    Hojker, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S450 - S450
  • [30] Recombinant TSH or thyroid hormone withdrawal?: A comparison of I-131 remnant ablation rates in thyroid cancer patients
    Luster, M
    Ladenson, P
    Pacini, F
    Schlumberger, M
    Driedger, A
    Kloos, R
    Sherman, S
    Corone, C
    Haugen, B
    Lassmann, M
    Hänscheid, H
    Reiners, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S291
12345